Severity Scoring Index for Crimean-Congo Hemorrhagic Fever and the Impact of Ribavirin and Corticosteroids on Fatality

Creative Commons License

Dokuzoguz B., Celikbas A. K., Gok Ş., Baykam N., Eroglu M. N., Ergonul O.

CLINICAL INFECTIOUS DISEASES, cilt.57, sa.9, ss.1270-1274, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 9
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1093/cid/cit527
  • Dergi Adı: CLINICAL INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1270-1274
  • Anahtar Kelimeler: Crimean-Congo hemorrhagic fever, severity scoring index, ribavirin, corticosteroids, ORAL RIBAVIRIN, RISK-FACTORS, EFFICACY, THERAPY, TURKEY
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Background. Patients infected with Crimean-Congo hemorrhagic fever (CCHF) virus present with a wide clinical spectrum. In observational studies, the effects of therapeutic agents are confounded by severity. We describe use of a clinical severity scoring index (SSI) for CCHF patients and assess the effect of ribavirin and corticosteroid therapy on the case-fatality rate, stratified by SSI.